Special Drug Use-Results Surveillance (all-case) for sotorasib in patients with KRAS G12C-mutated, unresectable, advanced and/or recurrent non-small-cell lung cancer, that has progressed after systemic anticancer therapy in Japan (20210051) First published 19/04/2022 Last updated 02/05/2024 EU PAS number:EUPAS46655 Study Ongoing